Group One Trading, L.P. Seres Therapeutics, Inc. Transaction History

Group One Trading, L.P.

$2.4 Billion
Q3 2024

A detailed history of Group One Trading, L.P. transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 193,518 shares of MCRB stock, worth $156,749. This represents 0.01% of its overall portfolio holdings.

Number of Shares

193,518

Previous 111,251 73.95%

Holding current value

$156,749

Previous $80,000 128.75%

% of portfolio

0.01%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.7 - $1.48 $57,586 - $121,755	82,267 Added 73.95%	193,518 $183,000
Q2 2024 Aug 14, 2024	BUY	$0.56 - $1.19 $29,386 - $62,445	52,475 Added 89.28%	111,251 $80,000
Q1 2024 May 10, 2024	SELL	$0.75 - $1.56 $9,362 - $19,473	-12,483 Reduced 17.52%	58,776 $45,000
Q4 2023 Feb 14, 2024	BUY	$0.93 - $2.15 $66,270 - $153,206	71,259 New	71,259 $99,000
Q1 2023 May 12, 2023	BUY	$4.95 - $6.09 $14,270 - $17,557	2,883 Added 10.59%	30,094 $170,000
Q4 2022 Feb 09, 2023	BUY	$5.09 - $9.05 $73,290 - $130,310	14,399 Added 112.39%	27,211 $152,000
Q3 2022 Nov 09, 2022	SELL	$3.5 - $7.2 $21,738 - $44,719	-6,211 Reduced 32.65%	12,812 $82,000
Q2 2022 Aug 11, 2022	SELL	$2.7 - $7.62 $118,611 - $334,746	-43,930 Reduced 69.78%	19,023 $65,000
Q1 2022 May 12, 2022	BUY	$6.3 - $8.84 $39,060 - $54,808	6,200 Added 10.92%	62,953 $448,000
Q4 2021 Feb 11, 2022	BUY	$6.02 - $11.43 $179,131 - $340,111	29,756 Added 110.22%	56,753 $473,000
Q3 2021 Nov 12, 2021	SELL	$5.46 - $22.6 $11,984 - $49,607	-2,195 Reduced 7.52%	26,997 $188,000
Q2 2021 Aug 10, 2021	SELL	$18.46 - $24.36 $604,897 - $798,228	-32,768 Reduced 52.89%	29,192 $696,000
Q1 2021 May 12, 2021	BUY	$17.66 - $28.92 $315,460 - $516,597	17,863 Added 40.51%	61,960 $1.28 Million
Q4 2020 Feb 10, 2021	BUY	$23.25 - $37.73 $1.03 Million - $1.66 Million	44,097 New	44,097 $1.08 Million
Q2 2018 Aug 14, 2018	SELL	$6.91 - $9.55 $13,930 - $19,252	-2,016 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$7.34 - $11.16 $14,797 - $22,498	2,016 New	2,016 $15,000
Q4 2017 Feb 09, 2018	SELL	$9.15 - $12.64 $22,573 - $31,182	-2,467 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$12.81 - $16.85 $31,602 - $41,568	2,467	2,467 $40,000

Others Institutions Holding MCRB

# of Institutions

Shares Held

40.5M

Call Options Held

304K

Put Options Held

471K

View Full List

About Seres Therapeutics, Inc.

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $100M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

More about MCRB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Seres Therapeutics, Inc. Transaction History